Latest / Stock Movers / Capri Rises; Apogee and Zscaler Sink
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: Let's take a look at some stocks on the move today.
- 0:18Speaker 1: I'm Nathan Hager, joined by Bloomberg's Dan Curtis. Continuing to
- 0:22Speaker 1: wind down earning season, we've got some pretty big names
- 0:26Speaker 1: reporting their results at this late stage, including Capri Holdings.
- 0:31Speaker 1: Still some story to be told in the luxury space.
- 0:34Speaker 1: Good morning Dan, Good morning Nathan.
- 0:36Speaker 3: That's right, the company behind Michael Cores and Jimmy cho
- 0:40Speaker 3: that is Capri Holdings. Those shares are up about three
- 0:42Speaker 3: percent in the pre market under ticker CPRII. The company's
- 0:46Speaker 3: fourth quarter revenue came in at seven hundred and ninety
- 0:49Speaker 3: six million dollars. That was about in line with estimates. However,
- 0:52Speaker 3: earnings came in at twenty two cents per share on
- 0:55Speaker 3: an adjusted level, twice what the Wall Street was expecting.
- 0:59Speaker 3: Company also said that sees twenty twenty seven first quarter
- 1:02Speaker 3: EPs of forty cents, also above estimates. So we're getting
- 1:05Speaker 3: a bottom line b out of that company. That's bring
- 1:08Speaker 3: those shares higher all right.
- 1:09Speaker 1: Now, we got some word that Appage is getting a
- 1:14Speaker 1: big cash in fusion, but investors don't look like they're
- 1:18Speaker 1: taking too kindly to this one.
- 1:19Speaker 3: Dan, It's a double dose of news for this biotech company.
- 1:23Speaker 3: And that's right. Appage ticker APGE is now down eighteen
- 1:27Speaker 3: percent in pre market. We saw it up double digits
- 1:29Speaker 3: before this. So we've had two pieces of news. So
- 1:32Speaker 3: we first have had news that Blackstone was providing up
- 1:35Speaker 3: to one point three billion dollars in financing. The money
- 1:38Speaker 3: will be used to help advance the skin drug to
- 1:40Speaker 3: treat multiple inflammatory diseases and a this is a drug
- 1:44Speaker 3: that app he's looking out to twenty twenty nine for
- 1:47Speaker 3: that pushed the shares up. However, since then, we've gotten
- 1:49Speaker 3: results from a clinical study not full stage from phase
- 1:54Speaker 3: two studies, but that has the shares down. This is
- 1:57Speaker 3: for the results from an apex try in moderate to
- 2:01Speaker 3: treat moderate to severe atopic dermatitis. The results from that
- 2:04Speaker 3: do not seem to be pleasing the market this morning.
- 2:06Speaker 1: Yeah, in a big way. With that eighteen percent drop
- 2:09Speaker 1: that you mentioned, and even bigger drop this morning for
- 2:13Speaker 1: z scaler. This is back to the earning story, right.
- 2:17Speaker 3: Yeah, back to the earning story and down twenty three
- 2:20Speaker 3: percent in the pre market under ticker zs Z. Scaler
- 2:23Speaker 3: is a cloud based cybersecurity company and its fiscal fourth
- 2:27Speaker 3: quarter revenue estimate was weaker than expected, so that has
- 2:30Speaker 3: the shares down despite the company beating third quarter top
- 2:33Speaker 3: and bottom line and estimates and increasing Foliar guidance. So
- 2:36Speaker 3: that's pointing towards weakness in the current period. The preliminary
- 2:40Speaker 3: annual recurring revenue for the next fiscal year of about
- 2:43Speaker 3: sixteen percent is indicating a slowdown and Bloomberg intelligences that
- 2:47Speaker 3: suggests muted new customer additions. So long term, there is
- 2:51Speaker 3: concern about that top line growth in the future with
- 2:54Speaker 3: potentially fewer new customers coming into the company.
- 2:57Speaker 1: All right, in the time we have left, let's move
- 2:59Speaker 1: back to the greens side of the screen. We've got
- 3:01Speaker 1: a new trillion dollar market cap company out there in
- 3:05Speaker 1: Micron dan.
- 3:07Speaker 3: Tick our Mu. It is up six percent in the
- 3:09Speaker 3: pre market on top of what on top of yesterday's game,
- 3:13Speaker 3: which push over that one trillion dollar market cap. As
- 3:15Speaker 3: you said, it's a memory company. This space has been
- 3:18Speaker 3: taking off overnight. We saw a competitor sk Heinex in Korea,
- 3:22Speaker 3: also topping one trillion dollars in market cap. Micron's move
- 3:26Speaker 3: comes off the back of UBS raising its price target
- 3:29Speaker 3: to about twice the stock price and applying shares could double.
- 3:32Speaker 3: It's bullish on the AI investment, saying that this this
- 3:36Speaker 3: breaks the traditional cycle goal pattern in memory companies now
- 3:40Speaker 3: seeing large back orders, which means demand could be out
- 3:42Speaker 3: kind of well beyond the typical waves of demand and
- 3:46Speaker 3: softness that these companies see. UBS's price target sixteen twenty
- 3:49Speaker 3: five is the street high, nearly five hundred dollars a
- 3:53Speaker 3: share higher than the second highest price target. All these
- 3:56Speaker 3: provide strong catalysts big momentum trade in pre market today.
- 4:00Speaker 2: This stockmover's report from Bloomberg Radio. Check back with us
- 4:04Speaker 2: throughout the day for the latest roundup of companies making
- 4:07Speaker 2: news on Wall Street and for the latest market moving headlines.
- 4:11Speaker 2: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 4:15Speaker 2: dot com, and on Applecarplay and Android Auto with the
- 4:18Speaker 2: Bloomberg Business app.